Health Gorilla & Amwell Expands Digital Diagnostic Lab Ordering for Clinicians

What You Should Know:

Health Gorilla, a leading interoperability provider, and Amwell, a global leader in hybrid care enablement, announced a new lab capability within Amwell’s virtual care platform that will enable providers to offer patients a more connected hybrid care experience.

 – With this expanded partnership, Health Gorilla’s lab automation system will empower providers on the Amwell Converge platform with access to a broader lab network and enhanced digital diagnostic data capabilities.

– Through Health Gorilla’s API, providers can place lab orders, review test results, and automate manual processes all from one platform – leading to faster diagnoses and improved patient outcomes.

Expanded Partnership Benefits

A patient’s medical journey is highly dependent on diagnostic lab results as up to 70% of clinical decisions are influenced by laboratory results, and around 30% of patient encounters result in a provider ordering a lab test. The Converge platform enables providers, insurers, patients and innovators to deliver more affordable, higher-quality care across all hybrid environments, including in-person, virtual, and automated care. As part of the expanded partnership, Health Gorilla’s lab automation system will optimize diagnostic ordering, which will increase the efficiency of Amwell clinicians, leading to faster diagnoses and improved patient outcomes. With access to Health Gorilla’s APIs within the Converge platform, providers can place lab orders electronically, review test results, and automate manual processes all from one platform.

“Health Gorilla’s lab automation system is leveraged by leading provider organizations to automate their clinical workflows, and we’re thrilled to add Amwell as our newest collaborator,” said Steve Yaskin, chief executive officer at Health Gorilla. “Labs are a critical variable in the patient’s care journey, and we’re proud to empower providers using the Amwell Converge platform with more access to diagnostic data.”